Prevention of Herpesviridae Infections by Cationic PEGylated Carbosilane Dendrimers

Infections caused by viruses from the Herpesviridae family produce some of the most prevalent transmitted diseases in the world, constituting a serious global public health issue. Some of the virus properties such as latency and the appearance of resistance to antiviral treatments complicate the development of effective therapies capable of facing the infection. In this context, dendrimers present themselves as promising alternatives to current treatments. In this study, we propose the use of PEGylated cationic carbosilane dendrimers as inhibitors of herpes simplex virus 2 (HSV-2) and human cytomegalovirus (HCMV)infections. Studies of mitochondrial toxicity, membrane integrity, internalization and viral infection inhibition indicated that G2-SN15-PEG, G3-SN31-PEG, G2-SN15-PEG fluorescein isothiocyanate (FITC) labeled and G3-SN31-PEG-FITC dendrimers are valid candidates to target HSV-2 and HCMV infections since they are biocompatible, can be effectively internalized and are able to significantly inhibit both infections. Later studies (including viral inactivation, binding inhibition, heparan sulphate proteoglycans (HSPG)binding and surface plasmon resonance assays) confirmed that inhibition takes place at first infection stages. More precisely, these studies established that their attachment to cell membrane heparan sulphate proteoglycans impede the interaction between viral glycoproteins and these cell receptors, thus preventing infection. Altogether, our research confirmed the high capacity of these PEGylated carbosilane dendrimers to prevent HSV-2 and HCMV infections, making them valid candidates as antiviral agents against Herpesviridae infections

Frequency and Characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.

Familial history of melanoma is a well-known risk factor for the disease, and 7% melanoma patients were reported to have a family history of melanoma. Data relating to the frequency and clinical and pathological characteristics of both familial and non-familial melanoma in Spain have been published, but these only include patients from specific areas of Spain and do not represent the data for the whole of Spain. PATIENTS AND METHODS: An observational study conducted by the Spanish Group of Melanoma (GEM) analyzed the family history of patients diagnosed with melanoma between 2011 and 2013 in the dermatology and oncology departments. RESULTS: In all, 1047 patients were analyzed, and 69 (6.6%) fulfilled criteria for classical familial melanoma (two or more first-degree relatives diagnosed with melanoma). Taking into account other risk factors for familial melanoma, such as multiple melanoma, pancreatic cancer in the family or second-degree relatives with melanoma, the number of patients fulfilling the criteria increased to 165 (15.8%). Using a univariate analysis, we determined that a Breslow index of less than 1 mm, negative mitosis, multiple melanoma, and a history of sunburns in childhood were more frequent in familial melanoma patients, but a multivariate analysis revealed no differences in any pathological or clinical factor between the two groups. CONCLUSIONS: Similar to that observed in other countries, familial melanoma accounts for 6.6% of melanoma diagnoses in Spain. Although no differences in the multivariate analysis were found, some better prognosis factors, such as Breslow index, seem more frequent in familial melanoma, which reflect a better early detection marker and/or a different biological behavior

A new waterborne chitosan-based polyurethane hydrogel as a vehicle to transplant bone marrow mesenchymal cells improved wound healing of ulcers in a diabetic rat model

[EN] Foot ulcers, a common complication of diabetes, can cause physical incapacity and are derived from several factors, including poor wound healing. New therapeutic strategies are needed to minimize this complication for the sake of patients' health. We therefore developed a new chitosan- polyurethane hydrogel membrane (HPUC) and the WA results confirmed that HPUC present low cytotoxicity and improved wound healing when used with mononuclear bone marrow fraction cells in the diabetic rat model. The biodegradable hydrogels were produced in block copolymer networks with a combination of chitosan blocks and biodegradable polyurethane. The membranes were characterized by FTIR, C-13-NMR and thermogravimetry. Swelling and hydrolytic degradation were also evaluated. The non-solubility of the membranes in good solvents and the chemical characterization confirmed that the network structure was formed between the PU and the chitosan through urea/urethane bonds. The findings confirm that the HPUC have interesting properties that make them suitable for wound healing applications.This work was funded by: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -doctoral fellowships to Viezzer, C (CAPES/PDSE-BEX: 1408/11-9) and the Spanish Ministry of Economy and Competitiveness (MINECO) through the MAT2016-76039-C4-1-R Project, including FEDER financial support. CIBER-BBN is an initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund.Viezzer, C.; Mazzuca, R.; Machado, DC.; Forte, MMDC.; Gómez Ribelles, JL. (2020). A new waterborne chitosan-based polyurethane hydrogel as a vehicle to transplant bone marrow mesenchymal cells improved wound healing of ulcers in a diabetic rat model. Carbohydrate Polymers. 231:1-10. https://doi.org/10.1016/j.carbpol.2019.115734S110231Ahmed, R., Tariq, M., Ali, I., Asghar, R., Noorunnisa Khanam, P., Augustine, R., & Hasan, A. (2018). Novel electrospun chitosan/polyvinyl alcohol/zinc oxide nanofibrous mats with antibacterial and antioxidant properties for diabetic wound healing. International Journal of Biological Macromolecules, 120, 385-393. doi:10.1016/j.ijbiomac.2018.08.057Andrade, F., Goycoolea, F., Chiappetta, D. A., das Neves, J., Sosnik, A., & Sarmento, B. (2011). Chitosan-Grafted Copolymers and Chitosan-Ligand Conjugates as Matrices for Pulmonary Drug Delivery. International Journal of Carbohydrate Chemistry, 2011, 1-14. doi:10.1155/2011/865704Baltzis, D., Eleftheriadou, I., & Veves, A. (2014). Pathogenesis and Treatment of Impaired Wound Healing in Diabetes Mellitus: New Insights. Advances in Therapy, 31(8), 817-836. doi:10.1007/s12325-014-0140-xBarikani, M., Honarkar, H., & Barikani, M. (2010). Synthesis and characterization of chitosan-based polyurethane elastomer dispersions. Monatshefte für Chemie - Chemical Monthly, 141(6), 653-659. doi:10.1007/s00706-010-0309-1Boulton, A. J. M. (2013). The Pathway to Foot Ulceration in Diabetes. Medical Clinics of North America, 97(5), 775-790. doi:10.1016/j.mcna.2013.03.007Casettari, L., Vllasaliu, D., Castagnino, E., Stolnik, S., Howdle, S., & Illum, L. (2012). PEGylated chitosan derivatives: Synthesis, characterizations and pharmaceutical applications. Progress in Polymer Science, 37(5), 659-685. doi:10.1016/j.progpolymsci.2011.10.001Chen, L., Tredget, E. E., Wu, P. Y. G., & Wu, Y. (2008). Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing. PLoS ONE, 3(4), e1886. doi:10.1371/journal.pone.0001886Chen, S.-H., Tsao, C.-T., Chang, C.-H., Wu, Y.-M., Liu, Z.-W., Lin, C.-P., … Hsieh, K.-H. (2012). Synthesis and characterization of thermal-responsive chitin-based polyurethane copolymer as a smart material. Carbohydrate Polymers, 88(4), 1483-1487. doi:10.1016/j.carbpol.2012.01.055Ching Ting Tsao, Chih Hao Chang, Yu Dar Li, Ming Fung Wu, Chun Pin Lin, Jin Lin Han, … Kuo Huang Hsieh. (2011). Development of chitosan/ dicarboxylic acid hydrogels as wound dressing materials. Journal of Bioactive and Compatible Polymers, 26(5), 519-536. doi:10.1177/0883911511422627De Britto, D., & Campana-Filho, S. P. (2007). Kinetics of the thermal degradation of chitosan. Thermochimica Acta, 465(1-2), 73-82. doi:10.1016/j.tca.2007.09.008De Moura, M. R., Aouada, F. A., & Mattoso, L. H. C. (2008). Preparation of chitosan nanoparticles using methacrylic acid. Journal of Colloid and Interface Science, 321(2), 477-483. doi:10.1016/j.jcis.2008.02.006Dinh, T., Tecilazich, F., Kafanas, A., Doupis, J., Gnardellis, C., Leal, E., … Veves, A. (2012). Mechanisms Involved in the Development and Healing of Diabetic Foot Ulceration. Diabetes, 61(11), 2937-2947. doi:10.2337/db12-0227Eming, S. A., Martin, P., & Tomic-Canic, M. (2014). Wound repair and regeneration: Mechanisms, signaling, and translation. Science Translational Medicine, 6(265). doi:10.1126/scitranslmed.3009337Escobar Ivirico, J. L., Salmerón-Sánchez, M., Gómez Ribelles, J. L., & Monleón Pradas, M. (2009). Poly(l-lactide) networks with tailored water sorption. Colloid and Polymer Science, 287(6), 671-681. doi:10.1007/s00396-009-2026-zFlory, P. J., & Rehner, J. (1943). Statistical Mechanics of Cross‐Linked Polymer Networks II. Swelling. The Journal of Chemical Physics, 11(11), 521-526. doi:10.1063/1.1723792Gámiz-González, M. A., Vidaurre, A., & Gómez Ribelles, J. L. (2017). Biodegradable chitosan-poly(Ɛ-caprolactone) dialdehyde copolymer networks for soft tissue engineering. Polymer Degradation and Stability, 138, 47-54. doi:10.1016/j.polymdegradstab.2017.02.005García-Pacios, V., Costa, V., Colera, M., & Martín-Martínez, J. M. (2011). Waterborne polyurethane dispersions obtained with polycarbonate of hexanediol intended for use as coatings. Progress in Organic Coatings, 71(2), 136-146. doi:10.1016/j.porgcoat.2011.01.006García Cruz, D. M., Gomez Ribelles, J. L., & Salmerón Sánchez, M. (2008). Blending polysaccharides with biodegradable polymers. I. Properties of chitosan/polycaprolactone blends. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 85B(2), 303-313. doi:10.1002/jbm.b.30947Heux, L., Brugnerotto, J., Desbrières, J., Versali, M.-F., & Rinaudo, M. (2000). Solid State NMR for Determination of Degree of Acetylation of Chitin and Chitosan. Biomacromolecules, 1(4), 746-751. doi:10.1021/bm000070yHilfiker, A., Kasper, C., Hass, R., & Haverich, A. (2011). Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation? Langenbeck’s Archives of Surgery, 396(4), 489-497. doi:10.1007/s00423-011-0762-2Mohd Hilmi, A. B., Halim, A. S., Hassan, A., Lim, C. K., Noorsal, K., & Zainol, I. (2013). In vitro characterization of a chitosan skin regenerating template as a scaffold for cells cultivation. SpringerPlus, 2(1). doi:10.1186/2193-1801-2-79Hu, Y., Liu, Y., Qi, X., Liu, P., Fan, Z., & Li, S. (2011). Novel bioresorbable hydrogels prepared from chitosan-graft-polylactide copolymers. Polymer International, 61(1), 74-81. doi:10.1002/pi.3150Jiang, T., Nukavarapu, S. P., Deng, M., Jabbarzadeh, E., Kofron, M. D., Doty, S. B., … Laurencin, C. T. (2010). Chitosan–poly(lactide-co-glycolide) microsphere-based scaffolds for bone tissue engineering: In vitro degradation and in vivo bone regeneration studies. Acta Biomaterialia, 6(9), 3457-3470. doi:10.1016/j.actbio.2010.03.023Jiang, X., Li, J., Ding, M., Tan, H., Ling, Q., Zhong, Y., & Fu, Q. (2007). Synthesis and degradation of nontoxic biodegradable waterborne polyurethanes elastomer with poly(ε-caprolactone) and poly(ethylene glycol) as soft segment. European Polymer Journal, 43(5), 1838-1846. doi:10.1016/j.eurpolymj.2007.02.029Jovanovic, D., Engels, G. E., Plantinga, J. A., Bruinsma, M., van Oeveren, W., Schouten, A. J., … Harmsen, M. C. (2010). Novel polyurethanes with interconnected porous structure induce in vivo tissue remodeling and accompanied vascularization. Journal of Biomedical Materials Research Part A, 95A(1), 198-208. doi:10.1002/jbm.a.32817Koehler, J., Brandl, F. P., & Goepferich, A. M. (2018). Hydrogel wound dressings for bioactive treatment of acute and chronic wounds. European Polymer Journal, 100, 1-11. doi:10.1016/j.eurpolymj.2017.12.046Kuo, Y.-R., Wang, C.-T., Cheng, J.-T., Wang, F.-S., Chiang, Y.-C., & Wang, C.-J. (2011). Bone Marrow–Derived Mesenchymal Stem Cells Enhanced Diabetic Wound Healing through Recruitment of Tissue Regeneration in a Rat Model of Streptozotocin-Induced Diabetes. Plastic and Reconstructive Surgery, 128(4), 872-880. doi:10.1097/prs.0b013e3182174329Leventis, N., Sotiriou-Leventis, C., Chandrasekaran, N., Mulik, S., Larimore, Z. J., Lu, H., … Mang, J. T. (2010). Multifunctional Polyurea Aerogels from Isocyanates and Water. A Structure−Property Case Study. Chemistry of Materials, 22(24), 6692-6710. doi:10.1021/cm102891dMarchant, R. E., Zhao, Q., Anderson, J. M., & Hiltner, A. (1987). Degradation of a poly(ether urethane urea) elastomer: infra-red and XPS studies. Polymer, 28(12), 2032-2039. doi:10.1016/0032-3861(87)90037-1Marcos-Fernández, A., Abraham, G. A., Valentín, J. L., & Román, J. S. (2006). Synthesis and characterization of biodegradable non-toxic poly(ester-urethane-urea)s based on poly(ε-caprolactone) and amino acid derivatives. Polymer, 47(3), 785-798. doi:10.1016/j.polymer.2005.12.007Masson-Meyers, D. S., Bumah, V. V., & Enwemeka, C. S. (2016). A comparison of four methods for determining viability in human dermal fibroblasts irradiated with blue light. Journal of Pharmacological and Toxicological Methods, 79, 15-22. doi:10.1016/j.vascn.2016.01.001Merchant, Z., Taylor, K. M. G., Stapleton, P., Razak, S. A., Kunda, N., Alfagih, I., … Somavarapu, S. (2014). Engineering hydrophobically modified chitosan for enhancing the dispersion of respirable microparticles of levofloxacin. European Journal of Pharmaceutics and Biopharmaceutics, 88(3), 816-829. doi:10.1016/j.ejpb.2014.09.005Moise, M., Şunel, V., Holban, M., Popa, M., Desbrieres, J., Peptu, C., & Lionte, C. (2012). Double crosslinked chitosan and gelatin submicronic capsules entrapping aminoacid derivatives with potential antitumoral activity. Journal of Materials Science, 47(23), 8223-8233. doi:10.1007/s10853-012-6719-1Neto, C. G. T., Giacometti, J. A., Job, A. E., Ferreira, F. C., Fonseca, J. L. C., & Pereira, M. R. (2005). Thermal Analysis of Chitosan Based Networks. Carbohydrate Polymers, 62(2), 97-103. doi:10.1016/j.carbpol.2005.02.022Ouyang, Q.-Q., Hu, Z., Lin, Z.-P., Quan, W.-Y., Deng, Y.-F., Li, S.-D., … Chen, Y. (2018). Chitosan hydrogel in combination with marine peptides from tilapia for burns healing. International Journal of Biological Macromolecules, 112, 1191-1198. doi:10.1016/j.ijbiomac.2018.01.217Page, J. M., Prieto, E. M., Dumas, J. E., Zienkiewicz, K. J., Wenke, J. C., Brown-Baer, P., & Guelcher, S. A. (2012). Biocompatibility and chemical reaction kinetics of injectable, settable polyurethane/allograft bone biocomposites. Acta Biomaterialia, 8(12), 4405-4416. doi:10.1016/j.actbio.2012.07.037Park, W. S., Ahn, S. Y., Sung, S. I., Ahn, J.-Y., & Chang, Y. S. (2017). Strategies to enhance paracrine potency of transplanted mesenchymal stem cells in intractable neonatal disorders. Pediatric Research, 83(1-2), 214-222. doi:10.1038/pr.2017.249Pérez-Limiñana, M. A., Arán-Aís, F., Torró-Palau, A. M., César Orgilés-Barceló, A., & Miguel Martín-Martínez, J. (2005). Characterization of waterborne polyurethane adhesives containing different amounts of ionic groups. International Journal of Adhesion and Adhesives, 25(6), 507-517. doi:10.1016/j.ijadhadh.2005.02.002Pretsch, T., Jakob, I., & Müller, W. (2009). Hydrolytic degradation and functional stability of a segmented shape memory poly(ester urethane). Polymer Degradation and Stability, 94(1), 61-73. doi:10.1016/j.polymdegradstab.2008.10.012Rowlands, A. S., Lim, S. A., Martin, D., & Cooper-White, J. J. (2007). Polyurethane/poly(lactic-co-glycolic) acid composite scaffolds fabricated by thermally induced phase separation. Biomaterials, 28(12), 2109-2121. doi:10.1016/j.biomaterials.2006.12.032Abdel-Rahman, R. M., Abdel-Mohsen, A. M., Hrdina, R., Burgert, L., Fohlerova, Z., Pavliňák, D., … Jancar, J. (2016). Wound dressing based on chitosan/hyaluronan/nonwoven fabrics: Preparation, characterization and medical applications. International Journal of Biological Macromolecules, 89, 725-736. doi:10.1016/j.ijbiomac.2016.04.087Subramani, S., Park, Y.-J., Lee, Y.-S., & Kim, J.-H. (2003). New development of polyurethane dispersion derived from blocked aromatic diisocyanate. Progress in Organic Coatings, 48(1), 71-79. doi:10.1016/s0300-9440(03)00118-8Tao, Z., Shi, A., & Zhao, J. (2015). Epidemiological Perspectives of Diabetes. Cell Biochemistry and Biophysics, 73(1), 181-185. doi:10.1007/s12013-015-0598-4Ünlü, C., Pollet, E., & Avérous, L. (2018). Original Macromolecular Architectures Based on poly(ε-caprolactone) and poly(ε-thiocaprolactone) Grafted onto Chitosan Backbone. International Journal of Molecular Sciences, 19(12), 3799. doi:10.3390/ijms19123799Velazquez-Morales, P., Le Nest, J.-F., & Gandini, A. (1998). Polymer electrolytes derived from chitosan/polyether networks. Electrochimica Acta, 43(10-11), 1275-1279. doi:10.1016/s0013-4686(97)10030-5Wang, W., Ping, P., Chen, X., & Jing, X. (2006). Polylactide-based polyurethane and its shape-memory behavior. European Polymer Journal, 42(6), 1240-1249. doi:10.1016/j.eurpolymj.2005.11.029Yamane, T., Nakagami, G., Yoshino, S., Shimura, M., Kitamura, A., Kobayashi-Hattori, K., … Sanada, H. (2015). Hydrocellular foam dressings promote wound healing associated with decrease in inflammation in rat periwound skin and granulation tissue, compared with hydrocolloid dressings. Bioscience, Biotechnology, and Biochemistry, 79(2), 185-189. doi:10.1080/09168451.2014.968088Zawadzki, J., & Kaczmarek, H. (2010). Thermal treatment of chitosan in various conditions. Carbohydrate Polymers, 80(2), 394-400. doi:10.1016/j.carbpol.2009.11.037Zhang, S., Cheng, L., & Hu, J. (2003). NMR studies of water-borne polyurethanes. Journal of Applied Polymer Science, 90(1), 257-260. doi:10.1002/app.12696Zhang, S., Ren, Z., He, S., Zhu, Y., & Zhu, C. (2007). FTIR spectroscopic characterization of polyurethane-urea model hard segments (PUUMHS) based on three diamine chain extenders. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 66(1), 188-193. doi:10.1016/j.saa.2006.02.041Zuber, M., Zia, K. M., Mahboob, S., Hassan, M., & Bhatti, I. A. (2010). Synthesis of chitin–bentonite clay based polyurethane bio-nanocomposites. International Journal of Biological Macromolecules, 47(2), 196-200. doi:10.1016/j.ijbiomac.2010.04.02

Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage

Acetaminophen overdose is one of the leading causes of acute liver failure and liver transplantation in the Western world. Magnesium is essential in several cellular processess. The Cyclin M family is involved in magnesium transport across cell membranes. Herein, we identify that among all magnesium transporters, only Cyclin M4 expression is upregulated in the liver of patients with acetaminophen overdose, with disturbances in magnesium serum levels. In the liver, acetaminophen interferes with the mitochondrial magnesium reservoir via Cyclin M4, affecting ATP production and reactive oxygen species generation, further boosting endoplasmic reticulum stress. Importantly, Cyclin M4 mutant T495I, which impairs magnesium flux, shows no effect. Finally, an accumulation of Cyclin M4 in endoplasmic reticulum is shown under hepatoxicity. Based on our studies in mice, silencing hepatic Cyclin M4 within the window of 6 to 24 h following acetaminophen overdose ingestion may represent a therapeutic target for acetaminophen overdose induced liver injury

Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress.

INTRODUCTION The Unfolded Protein Response, a mechanism triggered by the cell in response to Endoplasmic reticulum stress, is linked to inflammatory responses. Our aim was to identify novel Unfolded Protein Response-mechanisms that might be involved in triggering or perpetuating the inflammatory response carried out by the Intestinal Epithelial Cells in the context of Inflammatory Bowel Disease. METHODS We analyzed the transcriptional profile of human Intestinal Epithelial Cell lines treated with an Endoplasmic Reticulum stress inducer (thapsigargin) and/or proinflammatory stimuli. Several genes were further analyzed in colonic biopsies from Ulcerative Colitis patients and healthy controls. Lastly, we generated Caco-2 cells lacking HMGCS2 by CRISPR Cas-9 and analyzed the functional implications of its absence in Intestinal Epithelial Cells. RESULTS Exposure to a TLR ligand after thapsigargin treatment resulted in a powerful synergistic modulation of gene expression, which led us to identify new genes and pathways that could be involved in inflammatory responses linked to the Unfolded Protein Response. Key differentially expressed genes in the array also exhibited transcriptional alterations in colonic biopsies from active Ulcerative Colitis patients, including NKG2D ligands and the enzyme HMGCS2. Moreover, functional studies showed altered metabolic responses and epithelial barrier integrity in HMGCS2 deficient cell lines. CONCLUSION We have identified new genes and pathways that are regulated by the Unfolded Protein Response in the context of Inflammatory Bowel Disease including HMGCS2, a gene involved in the metabolism of Short Chain Fatty Acids that may have an important role in intestinal inflammation linked to Endoplasmic Reticulum stress and the resolution of the epithelial damage.This work was supported by grants from Ministerio de Ciencia e Innovación (MCIN) from Spain [SAF2016-78711R and PID202-11794 to EM-N and FJC]; Comunidad de Madrid [B2017/BMD-3727 to EMN and FJC]; Comunidad de Madrid (REACT-UE, ANTICIPA-CM Ref. PR38/21-24) to E.M-N and HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679 to FJC the European Union’s Horizon 2020 research and innovation program [ERC-2016- Consolidator Grant 725091 to DS]; MCIN/AEI/10.13039/ 501100011033 [PID2019-108157RB to DS]; la Caixa Foundation (ID 100010434) [LCF/BQ/PR20/11770008 to SW]; Instituto de Salud Carlos III (ISCIII) [PI18/00348 to VE]; ISCIII [PI21/01641 to RT-R]; Spanish National Research and Development Plan, ISCIII and FEDER [PI17/02303 and PI20/01837 to SR-P]; Proyecto Desarrollo Tecnológico [DTS19/00111 to SR-P], AEI/MICIU EXPLORA Project [BIO2017-91272-EXP to SR-P]; Programa Estratégico Instituto de Biologıa y Gene ́ ́ tica Molecular (IBGM), Junta de Castilla y León (CCVC8485) [PID2019-104218RB-I00 to DB]; NIH [DK088199 to RB] and Universidad Complutense de Madrid (UCM 920631) [CT42/ 18-CT43/18 and EB15/21 to BM-A].S

Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura

Immune thrombotic thrombocytopenic purpura (iTTP) is a thrombotic microangiopathy caused by anti-ADAMTS13 antibodies. Caplacizumab is approved for adults with an acute episode of iTTP in conjunction with plasma exchange (PEX) and immunosuppression. The objective of this study was to analyze and compare the safety and efficacy of caplacizumab vs the standard of care and assess the effect of the concomitant use of rituximab. A retrospective study from the Spanish TTP Registry of patients treated with caplacizumab vs those who did not receive it was conducted. A total of 155 patients with iTTP (77 caplacizumab, 78 no caplacizumab) were included. Patients initially treated with caplacizumab had fewer exacerbations (4.5% vs 20.5%; P < .05) and less refractoriness (4.5% vs 14.1%; P < .05) than those who were not treated. Time to clinical response was shorter when caplacizumab was used as initial treatment vs caplacizumab used after refractoriness or exacerbation. The multivariate analysis showed that its use in the first 3 days after PEX was associated with a lower number of PEX (odds ratio, 7.5; CI, 2.3-12.7; P < .05) and days of hospitalization (odds ratio, 11.2; CI, 5.6-16.9; P < .001) compared with standard therapy. There was no difference in time to clinical remission in patients treated with caplacizumab compared with the use of rituximab. No severe adverse event was described in the caplacizumab group. In summary, caplacizumab reduced exacerbations and refractoriness compared with standard of care regimens. When administered within the first 3 days after PEX, it also provided a faster clinical response, reducing hospitalization time and the need for PEX

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

The natural history of cancers associated with virus exposure is intriguing, since only a minority of human tissues infected with these viruses inevitably progress to cancer. However, the molecular reasons why the infection is controlled or instead progresses to subsequent stages of tumorigenesis are largely unknown. In this article, we provide the first complete DNA methylomes of double-stranded DNA viruses associated with human cancer that might provide important clues to help us understand the described process. Using bisulfite genomic sequencing of multiple clones, we have obtained the DNA methylation status of every CpG dinucleotide in the genome of the Human Papilloma Viruses 16 and 18 and Human Hepatitis B Virus, and in all the transcription start sites of the Epstein-Barr Virus. These viruses are associated with infectious diseases (such as hepatitis B and infectious mononucleosis) and the development of human tumors (cervical, hepatic, and nasopharyngeal cancers, and lymphoma), and are responsible for 1 million deaths worldwide every year. The DNA methylomes presented provide evidence of the dynamic nature of the epigenome in contrast to the genome. We observed that the DNA methylome of these viruses evolves from an unmethylated to a highly methylated genome in association with the progression of the disease, from asymptomatic healthy carriers, through chronically infected tissues and pre-malignant lesions, to the full-blown invasive tumor. The observed DNA methylation changes have a major functional impact on the biological behavior of the viruses

The Fourteenth Data Release of the Sloan Digital Sky Survey: First Spectroscopic Data from the extended Baryon Oscillation Spectroscopic Survey and from the second phase of the Apache Point Observatory Galactic Evolution Experiment

The fourth generation of the Sloan Digital Sky Survey (SDSS-IV) has been in operation since July 2014. This paper describes the second data release from this phase, and the fourteenth from SDSS overall (making this, Data Release Fourteen or DR14). This release makes public data taken by SDSS-IV in its first two years of operation (July 2014-2016). Like all previous SDSS releases, DR14 is cumulative, including the most recent reductions and calibrations of all data taken by SDSS since the first phase began operations in 2000. New in DR14 is the first public release of data from the extended Baryon Oscillation Spectroscopic Survey (eBOSS); the first data from the second phase of the Apache Point Observatory (APO) Galactic Evolution Experiment (APOGEE-2), including stellar parameter estimates from an innovative data driven machine learning algorithm known as "The Cannon"; and almost twice as many data cubes from the Mapping Nearby Galaxies at APO (MaNGA) survey as were in the previous release (N = 2812 in total). This paper describes the location and format of the publicly available data from SDSS-IV surveys. We provide references to the important technical papers describing how these data have been taken (both targeting and observation details) and processed for scientific use. The SDSS website (www.sdss.org) has been updated for this release, and provides links to data downloads, as well as tutorials and examples of data use. SDSS-IV is planning to continue to collect astronomical data until 2020, and will be followed by SDSS-V.Comment: SDSS-IV collaboration alphabetical author data release paper. DR14 happened on 31st July 2017. 19 pages, 5 figures. Accepted by ApJS on 28th Nov 2017 (this is the "post-print" and "post-proofs" version; minor corrections only from v1, and most of errors found in proofs corrected